Drug
Volanesorsen
Volanesorsen: highest development phase Phase 3, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Volanesorsen NCT02658175 | Phase 3 | Familial Chylomicronemia Syndrome |
| volanesorsen NCT02527343 | Phase 2/3 | Familial Partial Lipodystrophy |
Latest
No recent events.
Follow Volanesorsen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.